-+ 0.00%
-+ 0.00%
-+ 0.00%

Oruka Therapeutics Q2 EPS $(0.55) Misses $(0.51) Estimate

Benzinga·08/10/2026 11:19:41
Listen to the news
Oruka Therapeutics (NASDAQ:ORKA) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.51) by 7.84 percent. This is a 19.57 percent decrease over losses of $(0.46) per share from the same period last year.